MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CATX — Perspective Therapeutics, Inc.
NYSE AmericanPerspective Therapeutics, Inc.
$2.76
+0.04(+1.47%)
- O
- 2.77
- H
- 2.82
- L
- 2.69
- V
- 2.62M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CATX
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateDec 29, 2003
Employees166
Stock ExchangeNYSE American
Ticker SymbolCATX
Key Financial Statistics
| Market Cap | $287.66M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.96 - $6.16 |
| 52-Week Avg Volume | 2.10M |
| VWAP | $2.76 |
| Transactions | 11,622 |
| Total Recorded Bars | 5,254 days |